Nuveen’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $545M | Sell |
5,265,836
-17,135
| -0.3% | -$1.53M | 0.13% | 123 |
|
|
2026
Q1 | $379M | Buy |
5,282,971
+93,375
| +2% | +$7.19M | 0.1% | 158 |
|
|
2025
Q4 | $412M | Buy |
5,189,596
+114,082
| +2% | +$8.99M | 0.11% | 153 |
|
|
2025
Q3 | $383M | Buy |
5,075,514
+1,486,576
| +41% | +$102M | 0.1% | 170 |
|
|
2025
Q2 | $248M | Buy |
3,588,938
+571,650
| +19% | +$37.5M | 0.07% | 230 |
|
|
2025
Q1 | $204M | Buy |
3,017,288
+26,726
| +0.9% | +$1.6M | 0.06% | 253 |
|
|
2024
Q4 | $134M | Sell |
2,990,562
-342,288
| -10% | -$19.2M | 0.04% | 342 |
|
|
2024
Q3 | $210M | Sell |
3,332,850
-87,784
| -3% | -$5.12M | 0.06% | 255 |
|
|
2024
Q2 | $202M | Sell |
3,420,634
-368,912
| -10% | -$23.1M | 0.06% | 248 |
|
|
2024
Q1 | $302M | Sell |
3,789,546
-20,248
| -0.5% | -$1.55M | 0.09% | 193 |
|
|
2023
Q4 | $301M | Sell |
3,809,794
-43,628
| -1% | -$3.11M | 0.1% | 180 |
|
|
2023
Q3 | $269M | Sell |
3,853,422
-124,676
| -3% | -$8.83M | 0.09% | 186 |
|
|
2023
Q2 | $275M | Sell |
3,978,098
-22,802
| -0.6% | -$1.62M | 0.1% | 176 |
|
|
2023
Q1 | $297M | Sell |
4,000,900
-483,965
| -11% | -$40.6M | 0.11% | 166 |
|
|
2022
Q4 | $418M | Sell |
4,484,865
-469,207
| -9% | -$45.3M | 0.16% | 131 |
|
|
2022
Q3 | $472M | Sell |
4,954,072
-60,930
| -1% | -$6.03M | 0.19% | 111 |
|
|
2022
Q2 | $465M | Sell |
5,015,002
-867,838
| -15% | -$84.7M | 0.18% | 117 |
|
|
2022
Q1 | $632M | Buy |
5,882,840
+1,165,354
| +25% | +$122M | 0.2% | 106 |
|
|
2021
Q4 | $487M | Sell |
4,717,486
-37,624
| -0.8% | -$3.48M | 0.14% | 135 |
|
|
2021
Q3 | $404M | Sell |
4,755,110
-130,855
| -3% | -$11M | 0.12% | 155 |
|
|
2021
Q2 | $408M | Sell |
4,885,965
-23,581
| -0.5% | -$1.93M | 0.12% | 163 |
|
|
2021
Q1 | $369M | Sell |
4,909,546
-814,760
| -14% | -$59.3M | 0.12% | 163 |
|
|
2020
Q4 | $391M | Sell |
5,724,306
-2,621,901
| -31% | -$171M | 0.13% | 144 |
|
|
2020
Q3 | $487M | Sell |
8,346,207
-850,214
| -9% | -$52.9M | 0.19% | 111 |
|
|
2020
Q2 | $597M | Sell |
9,196,421
-1,440,977
| -14% | -$90.7M | 0.24% | 88 |
|
|
2020
Q1 | $631M | Buy |
10,637,398
+9,670
| +0.1% | +$646K | 0.31% | 72 |
|
|
2019
Q4 | $790M | Sell |
10,627,728
-1,529,619
| -13% | -$107M | 0.3% | 66 |
|
|
2019
Q3 | $767M | Buy |
12,157,347
+45,303
| +0.4% | +$2.68M | 0.31% | 63 |
|
|
2019
Q2 | $660M | Buy |
12,112,044
+12,037,713
| +16,195% | +$648M | 0.26% | 79 |
|
|
2019
Q1 | $4.01M | Sell |
74,331
-537,888
| -88% | -$33.2M | 0.02% | 543 |
|
|
2018
Q4 | $40.1M | Sell |
612,219
-31,424
| -5% | -$2.35M | 0.25% | 84 |
|
|
2018
Q3 | $50.7M | Sell |
643,643
-330,372
| -34% | -$23.6M | 0.27% | 78 |
|
|
2018
Q2 | $62.7M | Buy |
974,015
+249,443
| +34% | +$16.4M | 0.39% | 47 |
|
|
2018
Q1 | $45.1M | Buy |
724,572
+86,377
| +14% | +$6.2M | 0.29% | 86 |
|
|
2017
Q4 | $46.3M | Buy |
638,195
+275,975
| +76% | +$20.1M | 0.3% | 82 |
|
|
2017
Q3 | $29.5M | Buy |
362,220
+254,598
| +237% | +$20.1M | 0.19% | 146 |
|
|
2017
Q2 | $8.66M | Sell |
107,622
-55,001
| -34% | -$4.34M | 0.06% | 436 |
|
|
2017
Q1 | $12.8M | Sell |
162,623
-174,007
| -52% | -$13.9M | 0.08% | 363 |
|
|
2016
Q4 | $26.6M | Buy |
336,630
+38,891
| +13% | +$3.15M | 0.13% | 170 |
|
|
2016
Q3 | $26.5M | Sell |
297,739
-11,887
| -4% | -$1.12M | 0.15% | 156 |
|
|
2016
Q2 | $29.6M | Sell |
309,626
-117,738
| -28% | -$11.7M | 0.18% | 136 |
|
|
2016
Q1 | $44.3M | Sell |
427,364
-41,897
| -9% | -$4.07M | 0.23% | 79 |
|
|
2015
Q4 | $45.9M | Sell |
469,261
-155,941
| -25% | -$15.3M | 0.24% | 79 |
|
|
2015
Q3 | $60.3M | Buy |
625,202
+2,249
| +0.4% | +$236K | 0.34% | 50 |
|
|
2015
Q2 | $65.3M | Sell |
622,953
-6,796
| -1% | -$694K | 0.35% | 55 |
|
|
2015
Q1 | $65M | Buy |
629,749
+32,092
| +5% | +$3.25M | 0.36% | 57 |
|
|
2014
Q4 | $57.6M | Buy |
597,657
+141,887
| +31% | +$12.5M | 0.32% | 63 |
|
|
2014
Q3 | $36.3M | Buy |
455,770
+22,639
| +5% | +$1.78M | 0.22% | 97 |
|
|
2014
Q2 | $32.6M | Sell |
433,131
-56,172
| -11% | -$4.25M | 0.2% | 119 |
|
|
2014
Q1 | $36.6M | Buy |
489,303
+122,610
| +33% | +$8.66M | 0.22% | 99 |
|
|
2013
Q4 | $26.2M | Buy |
366,693
+14,721
| +4% | +$946K | 0.17% | 171 |
|
|
2013
Q3 | $20M | Sell |
351,972
-15,698
| -4% | -$935K | 0.13% | 219 |
|
|
2013
Q2 | $21M | Buy |
+367,670
| New | +$21.3M | 0.14% | 200 |
|
Other funds holding CVS
Nuveen's CVS Position: Q2 2026 in Review
Nuveen reduced its CVS Health (CVS) stake by 0.32% in Q2 2026, selling an estimated $1.53M and leaving 5,265,836 shares worth $545M. The position accounts for 0.13% of the portfolio, ranked #123.
Nuveen first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $790M in Q4 2019. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Nuveen held 5,265,836 shares of CVS Health worth $545M as of Q2 2026.
- Nuveen sold 17,135 CVS Health shares in Q2 2026, an estimated $1.53M.
- CVS Health made up 0.13% of Nuveen's portfolio in Q2 2026, its #123 holding.
- Nuveen first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Nuveen's CVS Health position peaked at $790M in Q4 2019.
- 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.